Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 236

The DOI matches its Crossref record.

A specific B2‐bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril

Open access
Linz, Wolfgang, Schölkens, Bernward A.·1992·British Journal of Pharmacology

Abstract

To evaluate the role of bradykinin in the antihypertrophic effect of the angiotensin‐converting enzyme (ACE) inhibitor, ramipril, we investigated the influence of HOE 140, a specific B 2‐receptor antagonist, on the effects of ramipril on left ventricular hypertrophy (LVH) in rats with aortic banding. Ramipril at a dose of 1 mg kg−1 day−1 for 6 weeks prevented the increase in blood pressure and development of LVH after aortic banding; plasma ACE activity was significantly inhibited. A lower dose of ramipril (10 μg kg−1 May−1 for 6 weeks) had no effect on the increase in blood pressure or on plasma ACE activity, but prevented LVH after aortic banding. The antihypertrophic effects of the higher and the lower dose ramipril, as well as the antihypertensive action of the higher dose of ramipril were abolished by the coadministration of HOE 140 (500 μg kg−1 day−1). The present data show for the first time that the beneficial effects of an ACE‐inhibitor on LVH in rats with hypertension caused by aortic banding can be prevented by a specific B 2‐receptor antagonist.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.1992.tb09054.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 236

Metadata

Authors
Linz, W., & Schölkens, B. A.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1992-04
Volume
105
Issue
4
Pages
771-772
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2019114393
Cited by
236
References
0
FWCI
13.82
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A specific B2‐bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril. https://app.cochat.ai/papers/10.1111/j.1476-5381.1992.tb09054.x
The paper
Linz, W., & Schölkens, B. A. (1992). A specific B2‐bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1992.tb09054.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.